Morphic Holding Inc (MORF)
29.25
-3.20
(-9.86%)
USD |
NASDAQ |
May 17, 16:00
29.25
0.00 (0.00%)
After-Hours: 20:00
Morphic Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -6.94K% |
| December 31, 2022 | -397.3% |
| September 30, 2022 | -1.46K% |
| June 30, 2022 | 44.56% |
| March 31, 2022 | -1.32K% |
| December 31, 2021 | -224.0% |
| September 30, 2021 | -801.6% |
| June 30, 2021 | -722.8% |
| March 31, 2021 | -651.9% |
| Date | Value |
|---|---|
| December 31, 2020 | -300.8% |
| September 30, 2020 | 20.79% |
| June 30, 2020 | -206.1% |
| March 31, 2020 | -299.4% |
| December 31, 2019 | |
| September 30, 2019 | -156.2% |
| June 30, 2019 | -169.4% |
| March 31, 2019 | -85.70% |
| December 31, 2018 | -159.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.94K%
Minimum
Mar 2023
44.56%
Maximum
Jun 2022
-905.5%
Average
-300.8%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Keros Therapeutics Inc | -51.94K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |